Tilray Brands (TLRY) Current Leases (2017 - 2026)
Tilray Brands' (TLRY) quarterly Current Leases came in at $13.4 million in Q2 2026, up 92.44% YoY from $6.9 million in Q2 2025, and up 84.01% on a QoQ basis from $7.3 million in Q1 2026.
Tilray Brands (TLRY) Current Leases (2017 - 2026) Analysis & Trends
Tilray Brands (TLRY) has 10 years of Current Leases data on file, last reported at $13.4 million in Q2 2026.
- Quarterly Current Leases rose 92.44% year-over-year to $13.4 million in Q2 2026, while the trailing twelve-month figure through May 2026 was $13.4 million (up 92.44% YoY) and the FY2026 annual result came in at $13.4 million, up 92.44% from the prior year.
- Current Leases rose to $13.4 million in Q2 2026, from $7.3 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $13.4 million in Q2 2026 to a low of $2.3 million in Q3 2023.
- A 5-year average of $6.2 million and a median of $6.7 million in 2022 frame the typical range for Current Leases.
- Annual changes were most pronounced in 2023 — Current Leases slumped 68.12% — and 2024, when it jumped 142.69%.
- Tracing TLRY's Current Leases over 5 years: stood at $7.0 million in 2022, then declined by 27.71% to $5.0 million in 2023, then soared by 30.32% to $6.6 million in 2024, then grew by 13.16% to $7.4 million in 2025, then soared by 79.6% to $13.4 million in 2026.
- The last three Current Leases figures came in at $13.4 million (Q2 2026), $7.3 million (Q1 2026), and $7.4 million (Q4 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.89 Bn | 42.93 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.01 Bn | 39.35 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | - |
| 5 | United Therapeutics | 22.17 Bn | 19.51 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.85 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.51 Bn | 15.12 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.12 Bn | 9.96 Bn | - | - |
| 10 | Tilray Brands | 512.61 Mn | 277.98 Mn | 90.52 Mn | 13.36 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| May 31, 2026 | 13.36 Mn |
| Feb 28, 2026 | 7.26 Mn |
| Nov 30, 2025 | 7.44 Mn |
| Aug 31, 2025 | 7.48 Mn |
| May 31, 2025 | 6.94 Mn |
| Nov 30, 2024 | 6.57 Mn |
| Aug 31, 2024 | 5.64 Mn |
| May 31, 2024 | 5.09 Mn |
| Feb 29, 2024 | 5.42 Mn |
| Nov 30, 2023 | 5.04 Mn |
| Aug 31, 2023 | 2.32 Mn |
| May 31, 2023 | 2.42 Mn |
| Feb 28, 2023 | 2.53 Mn |
| Nov 30, 2022 | 6.98 Mn |
| Aug 31, 2022 | 7.29 Mn |
| May 31, 2022 | 6.70 Mn |
| Feb 28, 2022 | 6.70 Mn |
| Nov 30, 2021 | 3.59 Mn |
| Aug 31, 2021 | 3.81 Mn |
| May 31, 2021 | 4.26 Mn |